Search results: Sage Journals

Restricted accessResearch articleFirst published July, 2012

New EGFR-TKI: A case report of recurrent lung adenocarcinoma successfully treated with icotinib

Yulong Zheng, Weijia Fang, Xiao Liu [...]

Tumori Journal

Restricted accessResearch articleFirst published October, 2025

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis

Marco Stellato, Ernesto Zecca, Paola Bracchi [...]

Tumori Journal

Open accessResearch articleFirst published 2024

Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR -mutated non-small-cell lung cancer: a retrospective,multicenter cohort study

Ichidai Tanaka, Kazumi Hori, Junji Koyama [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2019

Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide,Population-Based Cohort Study

Chia-Ling Li, Te-Chun Hsia, Chia-Hsiang Li [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published November, 2014

Cardiac Metastasis from Renal Cell Carcinoma Successfully Treated with Pazopanib: Impact of TKIs' Antiangiogenic Activity

Giovanni Schinzari, Santa Monterisi, Diego Signorelli [...]

Tumori Journal

Open accessResearch articleFirst published 2024

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Fei Ye, Xiao Yuan, Wanjun Yu [...]

Technology in Cancer Research & Treatment

Open accessResearch articleFirst published April, 2021

The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs

Qiong He, Yamin Li, Xihong Zhou [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2025

Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs

Caifeng Gong, Jinglong Huang, Dandan Cao [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published May, 2021

Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs

Oscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín [...]

Cancer Biomarkers

Restricted accessResearch articleFirst published July, 2012

New EGFR-TKI: A case report of recurrent lung adenocarcinoma successfully treated with icotinib

Yulong Zheng, Weijia Fang, Xiao Liu [...]

Tumori Journal

Restricted accessResearch articleFirst published October, 2025

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis

Marco Stellato, Ernesto Zecca, Paola Bracchi [...]

Tumori Journal

Open accessResearch articleFirst published 2024

Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR -mutated non-small-cell lung cancer: a retrospective,multicenter cohort study

Ichidai Tanaka, Kazumi Hori, Junji Koyama [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2019

Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide,Population-Based Cohort Study

Chia-Ling Li, Te-Chun Hsia, Chia-Hsiang Li [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published November, 2014

Cardiac Metastasis from Renal Cell Carcinoma Successfully Treated with Pazopanib: Impact of TKIs' Antiangiogenic Activity

Giovanni Schinzari, Santa Monterisi, Diego Signorelli [...]

Tumori Journal

Open accessResearch articleFirst published 2024

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Fei Ye, Xiao Yuan, Wanjun Yu [...]

Technology in Cancer Research & Treatment

Open accessResearch articleFirst published April, 2021

The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs

Qiong He, Yamin Li, Xihong Zhou [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2025

Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs

Caifeng Gong, Jinglong Huang, Dandan Cao [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published May, 2021

Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs

Oscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín [...]

Cancer Biomarkers